San Francisco, CA—Breast Cancer Action (BCA), a national grassroots education and advocacy organization, announced today that it is joining with other health care advocates in demanding that Congress adopt legislation that will reform the Food & Drug Administration’s (FDA) drug approval process and protect the American public from unsafe drugs.

BCA joins the National Women’s Health Network, Our Bodies Ourselves, and the National Physicians Alliance in supporting these important legislative efforts.

“This legislation is essential to the public’s health,” says BCA Executive Director Barbara A. Brenner. “It is now clear, as it should have been before, that the FDA is no longer focused on drug safety from a public health perspective.”

BCA is also supporting legislation calling for the creation of an independent agency to evaluate drug safety.

“There is no question that the FDA’s dependence for funding on the pharmaceutical industry makes it impossible for the agency to do effective post-marketing safety studies,” says Brenner. “We need an independent body to make these important decisions.”

Breast Cancer Action is a national grassroots education and advocacy organization that carries the voices of people affected by breast cancer to inspire and compel the changes necessary to end the breast cancer epidemic.

Since 1998, BCA has refused to accept funds from corporations that may create a real or apparent conflict of interest for BCA. Corporations covered by this policy include pharmaceutical companies.

Mar 8 2019Before You Walk for Breast CancerEvery spring, breast cancer industry giants like Komen kick off their annual fundraising walks and runs. Here are 4 questions to ask before you participate or donate to one. ... read more

Breast Cancer Action has never been your typical breast cancer organization. We’re working to address and end the breast cancer epidemic at the intersection of breast cancer, the environment, social justice, and feminism.